F.DeFeliceetal.ANDROLOGY
preservationinfemaleandmalecancersurvivor
s.AsianJAndrol8,NationalComprehensiveCancerNetwork(2018e).Guidel
inesAcute
515–533.MyeloidLeukemia.Version1.2018.Availableat:http
://www.nccn.org/.
NationalComprehensiveCancerNetwork(2018a).Guide
linesTesticularStewartFA,AkleyevAV,Hauer-JensenM,HendryJH,Kleima
nNJ,
Cancer.Version2.2018.Availableat:http://www.nccn.org/.Macvi
ttieTJ,AlemanBM,EdgarAB,MabuchiK,MuirheadCR,Shore
NationalCompreh
ensiveCancerNetwork(2018b).GuidelinesAcuteRE&WallaceWH.(2012)ICR
Ppublication118:ICRPstatementon
LymphoblasticLeukemia.Version1.20
18.Availableat:http://www.tissuereactionsandearlyandlateeffectso
fradiationinnormal
nccn.org/.tissuesandorgans–thresholddosesfort
issuereactionsinaradiation
NationalComprehensiveCancerNetwork(201
8c).GuidelinesSoftTissueprotectioncontext.AnnICRP41,1–322.
Sarco
ma.Version1.2018.Availableat:http://www.nccn.org/.UNSCEAR(1977).
SourcesandEffectsofIonizingRadiation,pp.478–485.
NationalCompreh
ensiveCancerNetwork(2018d).GuidelinesUnitedNations,NewYork.
HodgkinLymphoma.Version3.2018.Availableat:http://www.nccVo
ginG&ForayN.(2013)ThelawofBergonieandTribondeau:anice
n.org/.for
mulafora?rstapproximation.IntJRadiatBiol89,2–8.
6Andrology,1–6?
2018AmericanSocietyofAndrologyandEuropeanAcademyofAndrology |
|
